Drug Information
| Drug General Information | Top | |||
|---|---|---|---|---|
| Drug ID |
D0D8KI
|
|||
| Former ID |
DIB012283
|
|||
| Drug Name |
Ad5-AC6
|
|||
| Synonyms |
Corgenic; AC6 gene therapy, Collateral/UCSD; Adenylyl cyclase gene therapy, Collateral/UCSD; CHF gene therapy, Collateral/UCSD; Gene therapy (CHF), Collateral/USCD; Gene therapy (adenylate cyclase), Collateral/USCD
Click to Show/Hide
|
|||
| Indication | Cardiac failure [ICD-11: BD10-BD13; ICD-10: I50, I50.9] | Terminated | [1] | |
| Company |
University of California San Diego
|
|||
| Target and Pathway | Top | |||
|---|---|---|---|---|
| Target(s) | Adenylate cyclase (ADCY) | Target Info | Modulator | [2] |
| References | Top | |||
|---|---|---|---|---|
| REF 1 | Trusted, scientifically sound profiles of drug programs, clinical trials, safety reports, and company deals, written by scientists. Springer. 2015. Adis Insight (drug id 800013170) | |||
| REF 2 | Unanticipated Signaling Events Associated with Cardiac Adenylyl Cyclase Gene Transfer. J Mol Cell Cardiol. 2011 May; 50(5): 751-758. | |||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.